{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T07:50:29Z","timestamp":1710921029740},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00347-011-2371-4","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T13:48:56Z","timestamp":1313675336000},"page":"777-787","source":"Crossref","is-referenced-by-count":6,"title":["Pharmakologische Therapie der Fr\u00fchgeborenenretinopathie"],"prefix":"10.1007","volume":"108","author":[{"given":"A.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jandeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Lagr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,20]]},"reference":[{"key":"2371_CR1","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","volume":"92","author":"Aiello","year":"1995","unstructured":"Aiello LP, Pierce EA, Foley ED et al (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 92:10457\u201310461","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2371_CR2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/jp.2009.166","volume":"30","author":"Atchaneeyasakul","year":"2010","unstructured":"Atchaneeyasakul LO, Trinavarat A (2010) Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity. J Perinatol 30:497\u2013499","journal-title":"J Perinatol"},{"key":"2371_CR3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.gt.3301680","volume":"9","author":"Bainbridge","year":"2002","unstructured":"Bainbridge JW, Mistry A, De Alwis M et al (2002) Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther 9:320\u2013326","journal-title":"Gene Ther"},{"key":"2371_CR4","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"2371_CR5","first-page":"91","volume":"35","author":"Bush","year":"1994","unstructured":"Bush RA, Malnoe A, Reme CE, Williams TP (1994) Dietary deficiency of N-3 fatty acids alters rhodopsin content and function in the rat retina. Invest Ophthalmol Vis Sci 35:91\u2013100","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2371_CR6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00134-009-1744-5","volume":"36","author":"Calder","year":"2010","unstructured":"Calder PC, Jensen GL, Koletzko BV et al (2010) Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med 36:735\u2013749","journal-title":"Intensive Care Med"},{"key":"2371_CR7","first-page":"E1014","volume":"258","author":"Caufriez","year":"1990","unstructured":"Caufriez A, Frankenne F, Englert Y et al (1990) Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 258:E1014\u2013E1019","journal-title":"Am J Physiol"},{"key":"2371_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MOP.0b013e3283423f35","volume":"23","author":"Chen","year":"2011","unstructured":"Chen J, Stahl A, Hellstrom A, Smith LE (2011) Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr 23(2):173\u2013178","journal-title":"Curr Opin Pediatr"},{"key":"2371_CR9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clnu.2009.02.004","volume":"28","author":"Cheung","year":"2009","unstructured":"Cheung HM, Lam HS, Tam YH et al (2009) Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr 28:209\u2013212","journal-title":"Clin Nutr"},{"key":"2371_CR10","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","volume":"245","author":"Chung","year":"2007","unstructured":"Chung EJ, Kim JH, Ahn HS, Koh HJ (2007) Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 245:1727\u20131730","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2371_CR11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"Connor","year":"2009","unstructured":"Connor KM, Krah NM, Dennison RJ et al (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4:1565\u20131573","journal-title":"Nat Protoc"},{"key":"2371_CR12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","volume":"13","author":"Connor","year":"2007","unstructured":"Connor KM, SanGiovanni JP, Lofqvist C et al (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13:868\u2013873","journal-title":"Nat Med"},{"key":"2371_CR13","doi-asserted-by":"crossref","first-page":"1032S","DOI":"10.1093\/ajcn\/66.4.1032S","volume":"66","author":"Crawford","year":"1997","unstructured":"Crawford MA, Costeloe K, Ghebremeskel K et al (1997) Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? Am J Clin Nutr 66:1032S\u20131041S","journal-title":"Am J Clin Nutr"},{"key":"2371_CR14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.2008.151233","volume":"93","author":"Lucena","year":"2009","unstructured":"Lucena D da R, Ribeiro JA, Costa RA et al (2009) Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study). Br J Ophthalmol 93:688\u2013691","journal-title":"Br J Ophthalmol"},{"key":"2371_CR15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0148607109332773","volume":"33","author":"Meijer","year":"2009","unstructured":"Meijer VE de, Gura KM, Le HD et al (2009) Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr 33:541\u2013547","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2371_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1203\/01.PDR.0000155950.67503.BC","volume":"57","author":"Engstrom","year":"2005","unstructured":"Engstrom E, Niklasson A, Wikland KA et al (2005) The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res 57:605\u2013610","journal-title":"Pediatr Res"},{"key":"2371_CR17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00417-008-1012-3","volume":"247","author":"Fortes","year":"2009","unstructured":"Fortes Filho JB, Bonomo PP, Maia M, Procianoy RS (2009) Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies. Graefes Arch Clin Exp Ophthalmol 247:831\u2013836","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2371_CR18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00347-008-1789-9","volume":"105","author":"Heckmann","year":"2008","unstructured":"Heckmann M (2008) Pathogenesis of retinopathy of prematurity. Ophthalmologe 105:1101\u20131107","journal-title":"Ophthalmologe"},{"key":"2371_CR19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","volume":"112","author":"Hellstrom","year":"2003","unstructured":"Hellstrom A, Engstrom E, Hard AL et al (2003) Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112:1016\u20131020","journal-title":"Pediatrics"},{"key":"2371_CR20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1651-2227.2009.01568.x","volume":"99","author":"Hellstrom","year":"2010","unstructured":"Hellstrom A, Ley D, Hansen-Pupp I et al (2010) New insights into the development of retinopathy of prematurity \u2013 importance of early weight gain. Acta Paediatr 99:502\u2013508","journal-title":"Acta Paediatr"},{"key":"2371_CR21","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","volume":"98","author":"Hellstrom","year":"2001","unstructured":"Hellstrom A, Perruzzi C, Ju M et al (2001) Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 98:5804\u20135808","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2371_CR22","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archophthalmol.2010.145","volume":"128","author":"Hoang","year":"2010","unstructured":"Hoang QV, Kiernan DF, Chau FY et al (2010) Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol 128:1080\u20131081","journal-title":"Arch Ophthalmol"},{"key":"2371_CR23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","volume":"246","author":"Honda","year":"2008","unstructured":"Honda S, Hirabayashi H, Tsukahara Y, Negi A (2008) Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246:1061\u20131063","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2371_CR24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1055\/s-0028-1109650","volume":"226","author":"Jandeck","year":"2009","unstructured":"Jandeck C (2009) New therapeutic approaches in the treatment of retinopathy of prematurity. Klin Monatsbl Augenheilkd 226:914\u2013920","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2371_CR25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2008-1027168","volume":"225","author":"Jandeck","year":"2008","unstructured":"Jandeck C, Kellner U, Lorenz B, Seiberth V (2008) Guidelines for ophthalmological screening of premature infants in Germany. Klin Monatsbl Augenheilkd 225:123\u2013130","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2371_CR26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaapos.2010.05.011","volume":"14","author":"Jang","year":"2010","unstructured":"Jang SY, Choi KS, Lee SJ (2010) Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity. J AAPOS 14:457\u2013459","journal-title":"J AAPOS"},{"key":"2371_CR27","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1053\/j.gastro.2005.10.066","volume":"130","author":"Kelly","year":"2006","unstructured":"Kelly DA (2006) Intestinal failure-associated liver disease: what do we know today? Gastroenterology 130:S70\u2013S77","journal-title":"Gastroenterology"},{"key":"2371_CR28","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","volume":"92","author":"Kusaka","year":"2008","unstructured":"Kusaka S, Shima C, Wada K et al (2008) Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 92:1450\u20131455","journal-title":"Br J Ophthalmol"},{"key":"2371_CR29","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/IAE.0b013e3181ca146b","volume":"30","author":"Kychenthal","year":"2010","unstructured":"Kychenthal A, Dorta P (2010) Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Retina 30:S32\u2013S36","journal-title":"Retina"},{"key":"2371_CR30","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","volume":"28","author":"Lalwani","year":"2008","unstructured":"Lalwani GA, Berrocal AM, Murray TG et al (2008) Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 28:S13\u2013S18","journal-title":"Retina"},{"key":"2371_CR31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00417-010-1375-0","volume":"248","author":"Lee","year":"2010","unstructured":"Lee JY, Chae JB, Yang SJ et al (2010) Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels. Graefes Arch Clin Exp Ophthalmol 248:1257\u20131262","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2371_CR32","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","volume":"124","author":"Lofqvist","year":"2006","unstructured":"Lofqvist C, Andersson E, Sigurdsson J et al (2006) Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 124:1711\u20131718","journal-title":"Arch Ophthalmol"},{"key":"2371_CR33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00347-008-1787-y","volume":"105","author":"Lorenz","year":"2008","unstructured":"Lorenz B (2008) Current ophthalmic aspects of acute retinopathy of prematurity. Ophthalmologe 105:1092\u20131100","journal-title":"Ophthalmologe"},{"key":"2371_CR34","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)61231-X","volume":"167","author":"Marneros","year":"2005","unstructured":"Marneros AG, Fan J, Yokoyama Y et al (2005) Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 167:1451\u20131459","journal-title":"Am J Pathol"},{"key":"2371_CR35","first-page":"474","volume":"43","author":"McLeod","year":"2002","unstructured":"McLeod DS, Taomoto M, Cao J et al (2002) Localization of VEGF receptor-2 (KDR\/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 43:474\u2013482","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2371_CR36","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/bjo.2005.068304","volume":"90","author":"McLoone","year":"2006","unstructured":"McLoone E, O\u2019Keefe M, McLoone S, Lanigan B (2006) Long term functional and structural outcomes of laser therapy for retinopathy of prematurity. Br J Ophthalmol 90:754\u2013759","journal-title":"Br J Ophthalmol"},{"key":"2371_CR37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOP.0b013e32832925f9","volume":"21","author":"Mintz-Hittner","year":"2009","unstructured":"Mintz-Hittner HA, Best LM (2009) Antivascular endothelial growth factor for retinopathy of prematurity. Curr Opin Pediatr 21:182\u2013187","journal-title":"Curr Opin Pediatr"},{"key":"2371_CR38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364:603\u2013615","journal-title":"N Engl J Med"},{"key":"2371_CR39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","volume":"28","author":"Mintz-Hittner","year":"2008","unstructured":"Mintz-Hittner HA, Kuffel RR Jr (2008) Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28:831\u2013838","journal-title":"Retina"},{"key":"2371_CR40","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00417-010-1430-x","volume":"248","author":"Nazari","year":"2010","unstructured":"Nazari H, Modarres M, Parvaresh MM, Falavarjani KG (2010) Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 248:1713\u20131718","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2371_CR41","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.08-1735","volume":"49","author":"Nguyen","year":"2008","unstructured":"Nguyen CT, Vingrys AJ, Bui BV (2008) Dietary omega-3 fatty acids and ganglion cell function. Invest Ophthalmol Vis Sci 49:3586\u20133594","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2371_CR42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"Nishijima","year":"2007","unstructured":"Nishijima K, Ng YS, Zhong L et al (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53\u201367","journal-title":"Am J Pathol"},{"key":"2371_CR43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/IAE.0b013e3181a3b848","volume":"29","author":"Nonobe","year":"2009","unstructured":"Nonobe NI, Kachi S, Kondo M et al (2009) Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab. Retina 29:579\u2013585","journal-title":"Retina"},{"key":"2371_CR44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0002-9440(10)64773-6","volume":"156","author":"Ozaki","year":"2000","unstructured":"Ozaki H, Seo MS, Ozaki K et al (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156:697\u2013707","journal-title":"Am J Pathol"},{"key":"2371_CR45","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00347-008-1788-x","volume":"105","author":"Pelken","year":"2008","unstructured":"Pelken L, Maier RF (2008) Risk factors and prevention of retinopathy of prematurity. Ophthalmologe 105:1108\u20131113","journal-title":"Ophthalmologe"},{"key":"2371_CR46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1651-2227.2009.01677.x","volume":"99","author":"Perez-Munuzuri","year":"2010","unstructured":"Perez-Munuzuri A, Fernandez-Lorenzo JR, Couce-Pico ML et al (2010) Serum levels of IGF1 are a useful predictor of retinopathy of prematurity. Acta Paediatr 99:519\u2013525","journal-title":"Acta Paediatr"},{"key":"2371_CR47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bjo.2007.128371","volume":"92","author":"Pieh","year":"2008","unstructured":"Pieh C, Agostini H, Buschbeck C et al (2008) VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol 92:689\u2013693","journal-title":"Br J Ophthalmol"},{"key":"2371_CR48","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1167\/iovs.09-4723","volume":"51","author":"Pieh","year":"2010","unstructured":"Pieh C, Kruger M, Lagreze WA et al (2010) Plasma sE-selectin in premature infants: a possible surrogate marker of retinopathy of prematurity. Invest Ophthalmol Vis Sci 51:3709\u20133713","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2371_CR49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","volume":"92","author":"Pierce","year":"1995","unstructured":"Pierce EA, Avery RL, Foley ED et al (1995) Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92:905\u2013909","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2371_CR50","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","volume":"114","author":"Pierce","year":"1996","unstructured":"Pierce EA, Foley ED, Smith LE (1996) Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114:1219\u20131228","journal-title":"Arch Ophthalmol"},{"key":"2371_CR51","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","volume":"28","author":"Quiroz-Mercado","year":"2008","unstructured":"Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML et al (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28:S19\u2013S25","journal-title":"Retina"},{"key":"2371_CR52","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.93.10.4851","volume":"93","author":"Robinson","year":"1996","unstructured":"Robinson GS, Pierce EA, Rook SL et al (1996) Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A 93:4851\u20134856","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2371_CR53","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"2371_CR54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","volume":"24","author":"SanGiovanni","year":"2005","unstructured":"SanGiovanni JP, Chew EY (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24:87\u2013138","journal-title":"Prog Retin Eye Res"},{"key":"2371_CR55","doi-asserted-by":"crossref","first-page":"69ra12","DOI":"10.1126\/scitranslmed.3001571","volume":"3","author":"Sapieha","year":"2011","unstructured":"Sapieha P, Stahl A, Chen J et al (2011) 5-lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of {omega}-3 polyunsaturated fatty acids. Sci Transl Med 3:69ra12","journal-title":"Sci Transl Med"},{"key":"2371_CR56","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","volume":"116","author":"Sato","year":"2009","unstructured":"Sato T, Kusaka S, Shimojo H, Fujikado T (2009) Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 116:1599\u20131603","journal-title":"Ophthalmology"},{"key":"2371_CR57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ajo.2010.08.037","volume":"151","author":"Sato","year":"2011","unstructured":"Sato T, Shima C, Kusaka S (2011) Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity. Am J Ophthalmol 151:353\u2013357, e35","journal-title":"Am J Ophthalmol"},{"key":"2371_CR58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0301-4738.73707","volume":"59","author":"Shah","year":"2011","unstructured":"Shah PK, Morris RJ, Narendran V, Kalpana N (2011) Visual acuity and electroretinography findings 3 (1\/2) years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol 59:73\u201374","journal-title":"Indian J Ophthalmol"},{"key":"2371_CR59","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1161\/01.CIR.98.19.2081","volume":"98","author":"Shyu","year":"1998","unstructured":"Shyu KG, Manor O, Magner M et al (1998) Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98:2081\u20132087","journal-title":"Circulation"},{"key":"2371_CR60","doi-asserted-by":"crossref","unstructured":"Silveira RC, Fortes Filho JB, Procianoy RS (2010) Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants. Invest Ophthalmol Vis Sci","DOI":"10.1167\/iovs.10-6279"},{"key":"2371_CR61","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cbpa.2007.05.004","volume":"148","author":"Singer","year":"2007","unstructured":"Singer D, Muhlfeld C (2007) Perinatal adaptation in mammals: the impact of metabolic rate. Comp Biochem Physiol A Mol Integr Physiol 148:780\u2013784","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"2371_CR62","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ejcn.2010.98","volume":"64","author":"Skouroliakou","year":"2010","unstructured":"Skouroliakou M, Konstantinou D, Koutri K et al (2010) A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr 64:940\u2013947","journal-title":"Eur J Clin Nutr"},{"key":"2371_CR63","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1167\/iovs.08-2584","volume":"49","author":"Smith","year":"2008","unstructured":"Smith LE (2008) Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture. Invest Ophthalmol Vis Sci 49:5177\u20135182","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2371_CR64","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","volume":"5","author":"Smith","year":"1999","unstructured":"Smith LE, Shen W, Perruzzi C et al (1999) Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5:1390\u20131395","journal-title":"Nat Med"},{"key":"2371_CR65","first-page":"101","volume":"35","author":"Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2371_CR66","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1097\/IAE.0b013e3181d37539","volume":"30","author":"Stahl","year":"2010","unstructured":"Stahl A, Buchwald A, Martin G et al (2010) Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina 30:1524\u20131529","journal-title":"Retina"},{"key":"2371_CR67","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2353\/ajpath.2010.100526","volume":"177","author":"Stahl","year":"2010","unstructured":"Stahl A, Chen J, Sapieha P et al (2010) Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol 177:2715\u20132723","journal-title":"Am J Pathol"},{"key":"2371_CR68","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1167\/iovs.10-5176","volume":"51","author":"Stahl","year":"2010","unstructured":"Stahl A, Connor KM, Sapieha P et al (2010) The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 51:2813\u20132826","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2371_CR69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCRESAHA.110.221317","volume":"107","author":"Stahl","year":"2010","unstructured":"Stahl A, Sapieha P, Connor KM et al (2010) Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy. Circ Res 107:495\u2013500","journal-title":"Circ Res"},{"key":"2371_CR70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","volume":"38","author":"Travassos","year":"2007","unstructured":"Travassos A, Teixeira S, Ferreira P et al (2007) Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 38:233\u2013237","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"2371_CR71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1203\/PDR.0b013e3181973dc8","volume":"65","author":"Vanhaesebrouck","year":"2009","unstructured":"Vanhaesebrouck S, Daniels H, Moons L et al (2009) Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatr Res 65:307\u2013310","journal-title":"Pediatr Res"},{"key":"2371_CR72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ophtha.2010.04.018","volume":"118","author":"Wu","year":"2011","unstructured":"Wu WC, Yeh PT, Chen SN et al (2011) Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan. Ophthalmology 118:176\u2013183","journal-title":"Ophthalmology"},{"key":"2371_CR73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1091-8531(97)90008-2","volume":"1","author":"Young","year":"1997","unstructured":"Young TL, Anthony DC, Pierce E et al (1997) Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS 1:105\u2013110","journal-title":"J AAPOS"},{"key":"2371_CR74","doi-asserted-by":"crossref","unstructured":"Zepeda-Romero LC, Liera-Garcia JA, Gutierrez-Padilla JA et al (2010) Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity. Eye (Lond) 24:931\u2013933","DOI":"10.1038\/eye.2009.156"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-011-2371-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-011-2371-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-011-2371-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T11:49:48Z","timestamp":1592826588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-011-2371-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["2371"],"URL":"https:\/\/doi.org\/10.1007\/s00347-011-2371-4","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}